Original Article

1. ImmuneScore as a novel RNA-based prognostic signature superior to PD-L1 in advanced nonsquamous NSCLC patients receiving chemotherapy combined with immune checkpoint inhibitor therapy

Review

1. Research progress of intestinal microbiota in targeted therapy and immunotherapy of colorectal cancer
2. Research advances in immunotherapy combined with DNA damage response inhibitors for liver cancer therapy
3. Neutrophils in the tumor microenvironment: role in tumor progression and potential targeted therapeutic strategy